Webb Michelle L, Cerrato Felecia, Rosen Heather, DiVasta Amy D, Greene Arin K, Labow Brian I
Adolescent Breast Clinic, Children's Hospital Boston and Harvard Medical School, 300 Longwood Ave., Boston, MA 02115, USA.
Ann Plast Surg. 2012 Mar;68(3):257-60. doi: 10.1097/SAP.0b013e3182145370.
It is not known whether obesity portends poorer outcomes following reduction mammaplasty in adolescent macromastia patients. We review symptoms in obese and nonobese adolescent macromastia patients and describe early outcomes following reduction mammaplasty. Demographics, operative details, and postoperative follow-up data were collected on 67 patients seen at our institution between 1997 and 2008. Variables were compared using 2-sample t tests or Pearson χ/Fisher exact tests. Mean age at surgery was 17.1 ± 1.6 years. Mean body mass index was 27.9 ± 4.5 kg/m, and 32.8% were obese. Thirty-four patients (50.7%) experienced minor complications; 1 patient experienced a major complication. Of patients with complications, obese patients reported a greater number than nonobese patients (P = 0.013). There were no differences in the type of complication or self-reported satisfaction between obese and nonobese patients 34.4 ± 25.7 weeks after surgery. Our findings suggest that reduction mammaplasty is well-tolerated in obese and nonobese adolescents with macromastia and that obesity is not an absolute contraindication to reduction mammaplasty in adolescents.
目前尚不清楚肥胖是否预示着青春期巨乳症患者行乳房缩小术后预后较差。我们回顾了肥胖和非肥胖青春期巨乳症患者的症状，并描述了乳房缩小术后的早期预后情况。收集了1997年至2008年在我们机构就诊的67例患者的人口统计学资料、手术细节和术后随访数据。使用双样本t检验或Pearsonχ²/ Fisher精确检验对变量进行比较。手术时的平均年龄为17.1±1.6岁。平均体重指数为27.9±4.5kg/m²，32.8%为肥胖患者。34例患者（50.7%）出现轻微并发症；1例患者出现严重并发症。在出现并发症的患者中，肥胖患者报告的并发症数量多于非肥胖患者（P = 0.013）。术后34.4±25.7周，肥胖和非肥胖患者在并发症类型或自我报告的满意度方面没有差异。我们的研究结果表明，肥胖和非肥胖的青春期巨乳症患者对乳房缩小术耐受性良好，肥胖并非青春期乳房缩小术的绝对禁忌证。
